vs
Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and SenesTech, Inc. (SNES). Click either name above to swap in a different company.
Bioceres Crop Solutions Corp. is the larger business by last-quarter revenue ($77.6M vs $421.0K, roughly 184.3× SenesTech, Inc.). Bioceres Crop Solutions Corp. runs the higher net margin — -9.6% vs -428.5%, a 418.9% gap on every dollar of revenue. On growth, SenesTech, Inc. posted the faster year-over-year revenue change (-16.0% vs -16.8%). Over the past eight quarters, SenesTech, Inc.'s revenue compounded faster (0.7% CAGR vs -8.4%).
Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.
SenesTech, Inc. is an agricultural biotechnology life-sciences company, specializing in fertility management as a form of pest control. The company's primary product, ContraPest is designed to make brown and black rats infertile. SenesTech is headquartered in Phoenix, Arizona.
BIOX vs SNES — Head-to-Head
Income Statement — Q1 2026 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $77.6M | $421.0K |
| Net Profit | $-7.4M | $-1.8M |
| Gross Margin | 46.8% | 55.3% |
| Operating Margin | 9.3% | -446.8% |
| Net Margin | -9.6% | -428.5% |
| Revenue YoY | -16.8% | -16.0% |
| Net Profit YoY | -20.2% | -43.7% |
| EPS (diluted) | $-0.12 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $421.0K | ||
| Q3 25 | $77.6M | $690.0K | ||
| Q2 25 | — | $625.0K | ||
| Q1 25 | $60.6M | $485.0K | ||
| Q4 24 | $98.8M | $501.0K | ||
| Q3 24 | $93.3M | $482.0K | ||
| Q2 24 | — | $459.0K | ||
| Q1 24 | $84.0M | $415.0K |
| Q4 25 | — | $-1.8M | ||
| Q3 25 | $-7.4M | $-1.3M | ||
| Q2 25 | — | $-1.6M | ||
| Q1 25 | $-1.6M | $-1.7M | ||
| Q4 24 | $605.2K | $-1.3M | ||
| Q3 24 | $-6.2M | $-1.5M | ||
| Q2 24 | — | $-1.6M | ||
| Q1 24 | $9.8M | $-1.8M |
| Q4 25 | — | 55.3% | ||
| Q3 25 | 46.8% | 62.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | 39.4% | 64.5% | ||
| Q4 24 | 42.0% | 60.9% | ||
| Q3 24 | 40.2% | 65.4% | ||
| Q2 24 | — | 54.2% | ||
| Q1 24 | 50.8% | 32.5% |
| Q4 25 | — | -446.8% | ||
| Q3 25 | 9.3% | -195.2% | ||
| Q2 25 | — | -258.2% | ||
| Q1 25 | 1.5% | -342.9% | ||
| Q4 24 | 14.5% | -250.9% | ||
| Q3 24 | 2.5% | -321.0% | ||
| Q2 24 | — | -349.0% | ||
| Q1 24 | 15.7% | -444.1% |
| Q4 25 | — | -428.5% | ||
| Q3 25 | -9.6% | -188.1% | ||
| Q2 25 | — | -258.6% | ||
| Q1 25 | -2.6% | -343.3% | ||
| Q4 24 | 0.6% | -250.5% | ||
| Q3 24 | -6.6% | -313.9% | ||
| Q2 24 | — | -345.1% | ||
| Q1 24 | 11.6% | -441.4% |
| Q4 25 | — | $0.48 | ||
| Q3 25 | $-0.12 | $-0.28 | ||
| Q2 25 | — | $-0.87 | ||
| Q1 25 | $-0.02 | $-1.28 | ||
| Q4 24 | $0.00 | $-0.15 | ||
| Q3 24 | $-0.10 | $-2.07 | ||
| Q2 24 | — | $-3.08 | ||
| Q1 24 | $0.14 | $-3.56 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.5M | $8.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $288.3M | $9.6M |
| Total Assets | $734.9M | $12.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.6M | ||
| Q3 25 | $15.5M | $10.2M | ||
| Q2 25 | — | $6.1M | ||
| Q1 25 | $38.5M | $1.7M | ||
| Q4 24 | $29.2M | $1.3M | ||
| Q3 24 | $32.3M | $2.5M | ||
| Q2 24 | — | $2.0M | ||
| Q1 24 | $16.4M | $3.6M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | $288.3M | $11.3M | ||
| Q2 25 | — | $7.0M | ||
| Q1 25 | $345.0M | $2.9M | ||
| Q4 24 | $346.3M | $2.5M | ||
| Q3 24 | $346.0M | $3.7M | ||
| Q2 24 | — | $3.1M | ||
| Q1 24 | $348.5M | $4.6M |
| Q4 25 | — | $12.8M | ||
| Q3 25 | $734.9M | $14.6M | ||
| Q2 25 | — | $10.4M | ||
| Q1 25 | $798.2M | $3.6M | ||
| Q4 24 | $835.2M | $3.3M | ||
| Q3 24 | $827.3M | $4.4M | ||
| Q2 24 | — | $4.0M | ||
| Q1 24 | $836.1M | $5.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $-1.7M |
| Free Cash FlowOCF − Capex | — | $-1.7M |
| FCF MarginFCF / Revenue | — | -398.3% |
| Capex IntensityCapex / Revenue | — | 3.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-5.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-1.7M | ||
| Q3 25 | $14.4M | $-1.4M | ||
| Q2 25 | — | $-1.1M | ||
| Q1 25 | $23.3M | $-1.6M | ||
| Q4 24 | $-5.4M | $-1.2M | ||
| Q3 24 | $5.2M | $-1.4M | ||
| Q2 24 | — | $-1.6M | ||
| Q1 24 | $-17.4M | $-1.8M |
| Q4 25 | — | $-1.7M | ||
| Q3 25 | — | $-1.4M | ||
| Q2 25 | — | $-1.2M | ||
| Q1 25 | — | $-1.6M | ||
| Q4 24 | — | $-1.2M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $-1.6M | ||
| Q1 24 | — | $-1.8M |
| Q4 25 | — | -398.3% | ||
| Q3 25 | — | -205.9% | ||
| Q2 25 | — | -191.5% | ||
| Q1 25 | — | -328.5% | ||
| Q4 24 | — | -246.1% | ||
| Q3 24 | — | -296.1% | ||
| Q2 24 | — | -354.2% | ||
| Q1 24 | — | -441.2% |
| Q4 25 | — | 3.1% | ||
| Q3 25 | — | 6.1% | ||
| Q2 25 | — | 7.5% | ||
| Q1 25 | — | 7.4% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | — | 5.8% | ||
| Q2 24 | — | 8.5% | ||
| Q1 24 | — | 0.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -8.85× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -1.78× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
